AMENDMENT NO. 1 TO RIGHTS AGREEMENTRights Agreement • September 15th, 2008 • Synovics Pharmaceuticals • Medicinal chemicals & botanical products • Delaware
Contract Type FiledSeptember 15th, 2008 Company Industry JurisdictionThis AMENDMENT NO. 1 (the “Amendment”) to the Rights Agreement (the “Agreement”) entered into as of September 8, 2006, by and between SYNOVICS PHARMACEUTICALS, INC., a Nevada corporation (the “Company”), and CONTINENTAL STOCK TRANSFER & TRUST COMPANY (the “Rights Agent”), is entered into as of May 9, 2008.
VOTING AGREEMENTVoting Agreement • September 15th, 2008 • Synovics Pharmaceuticals • Medicinal chemicals & botanical products • Nevada
Contract Type FiledSeptember 15th, 2008 Company Industry JurisdictionTHIS VOTING AGREEMENT (the “Agreement”) is made and entered into as of this 8th day of May 2008, by and among Ronald H. Lane, Ph.D. (“Lane”), RH Lane Limited Partnership, a Arizona limited partnership (“Lane LP” and together with Lane, the “Lane Holders”) Harcharan Singh (“Singh”), 2133820 Ontario, Inc., an Ontario company (“Ontario” and together with Singh, the “Singh Holders”), Maneesh Pharmaceuticals Ltd., an Indian corporation (“Maneesh”), Svizera Holdings BV, a Netherlands entity (“Svizera”), Vinay Sapte (“Sapte” and together with Maneesh and Svizera, the “Maneesh Holders”), Axiom Capital Management LLC (“Axiom”), and Indigo Securities LLC (“Indigo”, and, together with Axiom, the “IB Holders”) (the “Lane Holders”, Singh Holders”, “Maneesh Holders”, and the IB Holders to be collectively referred to as the “Stockholders”).